Medical weight loss refers to a managed program designed to help individuals lose weight using medically supervised strategies. This includes personalized diet plans, exercise regimens, behavioral therapy, and often medication. The goal is to achieve a healthier weight, which can reduce the risk of chronic diseases such as diabetes, hypertension, and heart disease.

PHENTERMINE COMBINATIONS WITH NALTREXONE CAPSULES

• Mechanism: Phentermine is a stimulant that suppresses appetite, while Naltrexone is typically used to block the effects of opioids or alcohol, but it also helps reduce the craving for food.
• Use in Weight Loss: Combining these medications can help increase the feeling of fullness, decrease appetite, and reduce food cravings, making it easier for patients to stick to a low-calorie diet.

TOPIRAMATE COMBINATION WITH NALTREXONE

• Mechanism: Topiramate, originally used as a seizure medication, also reduces appetite and causes feelings of fullness. Naltrexone works to block the parts of the brain that feel pleasure when consuming food.
• Use in Weight Loss: This combination works by both suppressing appetite and minimizing pleasure associated with eating, which can significantly reduce calorie intake.

PHENTERMINE + TOPIRAMATE CAPSULES

• Mechanism: Phentermine acts as an appetite suppressant, while topiramate increases satiety and makes food less appealing.
• Use in Weight Loss: The combination is very effective for weight loss due to its dual action in appetite suppression and satiety enhancement.

COMMERCIALLY AVAILABLE MEDICATIONS. OZEMPIC, WEGOVY, MOUNJARIO INJECTION

• Active Ingredient: Ozempic and Wegovy contain Semaglutide, whereas Mounjario contains Tirzepatide.
• Mechanism: Semaglutide mimics the glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. Tirzepatide combines the actions of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) to enhance this effect.
• Use in Weight Loss: These injections are used once weekly and help reduce hunger, improve control over eating, and lead to substantial weight loss.

SEMAGLUTIDE AND TIRZEPATIDE INJECTION

• Mechanism: Both act as incretin mimetics. Semaglutide mimics GLP-1 alone, whereas Tirzepatide mimics both GLP-1 and GIP.
• Use in Weight Loss: These medications not only improve blood sugar control but also lead to weight loss through decreased appetite and increased feelings of fullness.

VPharmacy provides valuable support in medical weight loss by customizing medications to meet individual patient needs. Whether through modifying dosages, combining multiple medications, or altering formulation types, these tailored solutions can enhance patient adherence and comfort, ultimately contributing to more effective weight management.